JBS (NYSE:JBS) FY 2025 earnings snapshot

JBS (NYSE:JBS) has reported its FY 2025 numbers with Q4 revenue of US$23.1 billion and basic EPS of US$0.43, alongside trailing twelve month EPS of US$1.89 on revenue of US$86.2 billion, setting the stage for a closer look at how the year stacked up. Over recent periods the company has seen quarterly revenue move from US$22.6 billion in Q3 2025 to US$23.1 billion in Q4 2025, while quarterly basic EPS shifted from US$0.52 to US$0.43 and annual earnings growth over the last year has been reported at 30.2%. With net profit margins sitting at 2.3% and analysts flagging mid single digit growth expectations, the latest print leaves investors weighing earnings momentum against relatively flat profitability.

See our full analysis for JBS.

With the headline figures on the table, the next step is to set these results against the widely held narratives around JBS to see which stories the numbers support and which they call into question.

2.3% margin with US$2.0b profit over the last year

• On a trailing twelve month basis JBS earned US$2.0b of net income on US$86.2b of revenue, which works out to a 2.3% net profit margin that is described as unchanged from a year earlier.
• What stands out for the bullish narrative is that one year earnings growth of 30.2% sits against a five year earnings decline of 16.7% per year, so:
  • Supporters pointing to multi protein exposure and investments in higher margin prepared foods see the recent US$2.0b profit as evidence the business can still generate sizable earnings through different livestock cycles.
  • At the same time, the flat 2.3% margin and the longer term decline rate highlight that the improvement tied to current protein conditions has not yet translated into structurally higher profitability, which bullish investors need to factor in.

Bulls argue this 2.3% margin and US$2.0b profit are the early signs of a longer earnings rebuild, so if that angle interests you it is worth checking how that case is set out in full 🐂 JBS Bull Case.

Interest coverage risk alongside 8.8x P/E

• The shares trade on a trailing P/E of 8.8x compared with 20.7x for the US Food industry and 40.7x for peers, while interest payments are flagged as not well covered by earnings, which puts valuation and financing side by side for anyone looking at the balance sheet.
• Skeptics focus on this mix of low multiple and flagged interest coverage, arguing the cautious narrative around leverage is still very relevant, because:
  • Weak interest cover means a larger part of that 2.3% margin has to go to servicing debt, which can limit how much of the US$2.0b in trailing earnings is truly flexible for dividends, buybacks or reinvestment.
  • The fact that valuation screens as inexpensive while this financing risk is present suggests the discount may reflect genuine concern about how comfortably the company can fund its growth and working capital needs if conditions become less favorable.

Skeptics point to the combination of a low P/E and flagged interest coverage as a key test for the cautious view, so it can be helpful to see how that argument is laid out side by side with the numbers 🐻 JBS Bear Case.

Analyst upside vs DCF and current US$16.64 price

• Analysts have a price target of US$20.67 compared with the current share price of US$16.64, and there is also a DCF fair value of US$16.58, so the targets and model values sit within a fairly tight range around where the stock trades now.
• Consensus narrative points to modest growth assumptions behind those numbers, and the earnings print helps you check how grounded that is, because:
  • Forecasts for earnings growth of about 8.6% per year and revenue growth of about 3.4% per year are paired with an expectation that net margin stays close to the current 2.3% level, so the story leans more on steady progress than on a sharp profitability reset.
  • With trailing EPS at US$1.89 and earnings of roughly US$2.0b already on the board, the gap between today’s results and what analysts are assuming is not huge in absolute terms, which makes it easier for you to compare their scenario with your own view of how sustainable current margins and volumes look.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for JBS on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With both concerns and optimism running through this story, it helps to move quickly from headline narratives to the underlying data and your own judgement. A good place to begin is with a closer look at the 5 key rewards and 1 important warning sign

See What Else Is Out There

JBS is operating with a thin 2.3% margin, has flagged interest coverage risk, and reports earnings that are still aligned with a longer term decline.

If you are uneasy about that combination of leverage pressure and limited profit cushion, it may be worth reviewing companies highlighted in our solid balance sheet and fundamentals stocks screener (39 results) for potentially stronger financial footing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.